EPTIS
BAM Logo

Clinical PT - Molecular Panel for Bloodstream Infections and Sepsis

[EP Cliníco - Painel Molecular para Infecções da Corrente Sanguínea e Sepse]

EPTIS factsheet 1453113 | Last revision 2025-11-26 | URL: https://www.eptis.bam.de/pts1453113 https://www.eptis.bam.de/pts1453113

PT provider
PT provider ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda
Based in Brazil
Language(s) Portuguese/ English / Spanish
Remarks
Keywords
Product groups Human test material
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilized cell suspension of 1mL Acinetobacter baumannii Routine methods of participants
Bacteroides fragilis Routine methods of participants
Candida albicans Routine methods of participants
Candida glabrata Routine methods of participants
Candida krusei Routine methods of participants
Candida parapsilosis Routine methods of participants
Candida spp. Routine methods of participants
Candida tropicalis Routine methods of participants
Cryptococcus neoformans/gattii Routine methods of participants
Enterobacter cloacae Routine methods of participants
Enterobacteriaceae Routine methods of participants
Enterococcus spp. Routine methods of participants
Escherichia coli Routine methods of participants
Haemophilus influenzae Routine methods of participants
Klebsiella oxytoca Routine methods of participants
Klebsiella pneumoniae Routine methods of participants
Listeria monocytogenes Routine methods of participants
Morganella morganii Routine methods of participants
Neisseria meningitidis Routine methods of participants
Proteus spp. Routine methods of participants
Proteus spp./Morganella morganii Routine methods of participants
Pseudomonas aeruginosa Routine methods of participants
Salmonella spp. Routine methods of participants
Serratia marcescens Routine methods of participants
Staphylococcus aureus Routine methods of participants
Staphylococcus sp. Routine methods of participants
Streptococcus agalactiae Routine methods of participants
Routine methods of participants
Streptococcus pneumoniae Routine methods of participants
Streptococcus pyogenes Routine methods of participants
Streptococcus spp. Routine methods of participants
bla CTX-M Routine methods of participants
blaSHV Routine methods of participants
GES Routine methods of participants
GIM Routine methods of participants
IMP3 Routine methods of participants
KPC Routine methods of participants
MecA Routine methods of participants
NDM Routine methods of participants
NMC/IMI Routine methods of participants
OXA-23 Routine methods of participants
OXA-24 Routine methods of participants
OXA-48 Routine methods of participants
OXA-51 Routine methods of participants
OXA-a58 Routine methods of participants
SME Routine methods of participants
SPM Routine methods of participants
VanA Routine methods of participants
VanB Routine methods of participants
VIM Routine methods of participants
Aims of the PT scheme
Target group of participants No restrictions
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Variable costs. For this information, please contact Controllab.
Regularly operated Yes (4 rounds per year)
Year of first operation 2023
Contact details of the PT provider
Provider Contact person
ControlLab Controle de Qualidade para Laboratórios Ltda
Rua Ana Neri 416 Benfica
20911-442 Rio de Janeiro
Brazil

Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Web: http://www.controllab.com.br http://www.controllab.com.br
Vinicius Biasoli
Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Email: eptis@controllab.com eptis@controllab.com
If you find any mistakes please contact the responsible EPTIS coordinator in Brazil, Mr Rodrigo Caciano de Sena. Mr Rodrigo Caciano de Sena.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5